DEEP VEIN THROMBOSIS (DVT) — POSTPARTUM

SCF ENCYCLOPEDIA ENTRY

DEEP VEIN THROMBOSIS (DVT) — POSTPARTUM

SCF-RDOS Registry Code: SCF-RDOS-PPD-VASC-001

Disease Type Classification: Postpartum Vascular Disorder → Venous Thromboembolic Disease Syndrome → Postpartum Deep Vein Thrombosis

Adaptive Module Activation:

• Universal Core Module
• Vascular Disease Expansion
• Hematologic Disease Expansion
• Thromboembolic Disease Expansion
• Endothelial Dysfunction Expansion
• Critical Care Expansion
• Pulmonary Embolism Expansion

⸻

1. SCOPE & POSITIONING

Etiology / Classification

Postpartum Deep Vein Thrombosis (DVT) is a venous thromboembolic disorder characterized by formation of thrombi within the deep venous system during the postpartum period, most commonly involving the lower extremities and pelvic veins.

The postpartum period represents one of the highest-risk physiologic states for venous thrombosis due to profound alterations in coagulation, vascular function, and blood flow dynamics.

Most common locations:

• Iliac veins
• Femoral veins
• Popliteal veins
• Calf veins
• Ovarian veins
• Pelvic venous plexuses

Risk factors include:

• Cesarean delivery
• Postpartum hemorrhage
• Obesity
• Advanced maternal age
• Immobility
• Preeclampsia
• Multiple gestation
• Inherited thrombophilia
• Antiphospholipid syndrome
• Severe infection
• Previous venous thromboembolism

Within the SCF framework, Postpartum DVT is classified as:

A postpartum thrombo-inflammatory vascular syndrome characterized by endothelial activation, hypercoagulability, venous stasis, fibrin-rich thrombus formation, impaired venous circulation, and risk of pulmonary embolic dissemination.

⸻

2. SCF CLASSIFICATION

SCF Disease Category

Postpartum Venous Thromboembolic Syndrome

SCF Functional Class

Maternal Venous Circulatory Obstruction Disorder

SCF Fault Tier Classification

⸻

3. CLINICAL SIGNIFICANCE

Postpartum DVT is a major cause of maternal morbidity and mortality worldwide.

The greatest danger is thrombus embolization into the pulmonary circulation.

Potential complications include:

• Pulmonary Embolism (PE)
• Recurrent Venous Thromboembolism
• Post-Thrombotic Syndrome
• Chronic Venous Insufficiency
• Venous Ulceration
• Right Ventricular Strain
• Hemodynamic Collapse
• Maternal Death

⸻

4. SCF DOMAIN ALIGNMENT

Primary Domains

• Vascular
• Hematologic
• Endothelial
• Thromboembolic

Secondary Domains

• Cardiovascular
• Immunologic
• Critical Care
• Pulmonary

⸻

5. ETIOPATHOGENIC CORE

Primary Cause

Postpartum DVT develops when physiologic postpartum hypercoagulability combines with endothelial injury and venous stasis, resulting in intravascular thrombus formation.

The disorder reflects pathologic amplification of:

Virchow’s Triad

• Hypercoagulability
• Endothelial injury
• Venous stasis

These three forces converge to generate thrombus formation within deep veins.

⸻

Key Drivers

Driver A — Hypercoagulability

Pregnancy and postpartum physiology produce:

• Increased fibrinogen
• Increased clotting factors
• Reduced fibrinolysis

Result:

• Enhanced clot formation

⸻

Driver B — Endothelial Injury

Sources include:

• Delivery trauma
• Surgical intervention
• Inflammation
• Infection

Result:

• Prothrombotic endothelial activation

⸻

Driver C — Venous Stasis

Contributors include:

• Reduced mobility
• Venous compression
• Postoperative recovery

Result:

• Sluggish blood flow

⸻

Driver D — Thrombo-Inflammatory Amplification

Activated platelets and leukocytes promote:

• Fibrin deposition
• Coagulation cascade activation

Result:

• Thrombus propagation

⸻

Driver E — Embolic Dissemination

Thrombus fragments may detach and travel to:

• Pulmonary arteries

Result:

• Pulmonary embolism

⸻

6. SCF FAULT ARCHITECTURE

⸻

7. PATHOGENESIS FLOW (SCF LOGIC)

Postpartum State

↓

Hypercoagulability

Endothelial Injury

Venous Stasis

↓

Coagulation Activation

↓

Platelet Recruitment

↓

Fibrin Deposition

↓

Deep Vein Thrombosis

↓

Venous Obstruction

↓

Local Inflammation

↓

Thrombus Extension

↓

Pulmonary Embolism Risk

↓

Cardiopulmonary Compromise

⸻

8. CLINICAL SPECTRUM

⸻

9. SCF TRINITY FRAMEWORK MAPPING

Trinity Axis I — Structural Integrity

Affected Systems:

• Deep veins
• Venous valves
• Endothelium
• Pelvic venous plexuses

Primary Failure:

• Venous lumen obstruction

⸻

Trinity Axis II — Energetic Integrity

Affected Systems:

• Tissue perfusion
• Venous return systems
• Cellular oxygen delivery

Primary Failure:

• Impaired circulatory energetics

⸻

Trinity Axis III — Informational Integrity

Affected Systems:

• Coagulation signaling
• Endothelial communication networks
• Platelet activation pathways

Primary Failure:

• Dysregulated thrombosis signaling

⸻

10. DVT EXPANSION MODULE

Clinical Subtype Registry

Type A

Distal Lower Extremity DVT

Characteristics:

• Calf vein involvement
• Lower embolic risk

⸻

Type B

Proximal Lower Extremity DVT

Characteristics:

• Femoral or iliac involvement
• Higher embolic potential

⸻

Type C

Pelvic Vein Thrombosis

Characteristics:

• Pelvic venous system involvement
• Often postpartum-specific

⸻

Type D

Ovarian Vein Thrombosis

Characteristics:

• Postpartum predominance
• Pelvic pain presentation

⸻

Type E

Massive Thromboembolic Syndrome

Characteristics:

• Extensive thrombosis
• High pulmonary embolism risk

⸻

11. MULTI-OMICS PATHOGENESIS MAP

⸻

12. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Objectives

Prevent thrombus formation during the postpartum period.

Targets:

• Hypercoagulability
• Venous stasis
• Endothelial injury
• High-risk patient identification

Interventions:

• Early mobilization
• Mechanical prophylaxis
• Risk-stratified anticoagulation

⸻

CURATIVE

Objectives

Prevent thrombus extension and embolization.

Targets:

• Existing thrombus
• Coagulation activation
• Inflammatory amplification
• Venous obstruction

Interventions:

• Anticoagulation therapy
• Hemodynamic monitoring
• Thromboembolism surveillance

⸻

RESTORATIVE

Objectives

Restore venous integrity and prevent chronic complications.

Targets:

• Endothelial recovery
• Venous valve preservation
• Circulatory restoration
• Post-thrombotic syndrome prevention

Potential SCF Strategies:

• SCF-derived endothelial regeneration platforms
• Precision anticoagulant modulation systems
• Venous remodeling therapeutics
• Thrombo-inflammatory resolution technologies

⸻

13. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Clinical Assessment

Common findings:

• Unilateral leg swelling
• Leg pain
• Calf tenderness
• Increased limb circumference
• Warmth
• Erythema

Pelvic thrombosis may present with:

• Pelvic pain
• Flank pain
• Fever

⸻

Laboratory Evaluation

• CBC
• Coagulation profile
• D-dimer (limited postpartum specificity)
• Thrombophilia testing when indicated

⸻

Imaging

Primary diagnostic modality:

• Compression venous ultrasonography

Additional studies:

• CT venography
• MR venography

For pelvic thrombosis:

• CT pelvis
• MRI pelvis

⸻

Treatment

Anticoagulation

Primary therapy includes:

• Low-molecular-weight heparin
• Other guideline-directed anticoagulation strategies

⸻

Monitoring

Evaluate for:

• Thrombus progression
• Pulmonary embolism
• Bleeding complications

⸻

Advanced Intervention

In selected severe cases:

• Catheter-directed therapy
• Mechanical thrombectomy
• Inferior vena cava filter placement

⸻

14. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

SCF Target Cluster A

Precision Antithrombotic Platform

Targets:

• Excess coagulation
• Fibrin formation
• Platelet activation

⸻

SCF Target Cluster B

Endothelial Restoration Platform

Targets:

• Endothelial resilience
• Vascular repair
• Antithrombotic signaling

⸻

SCF Target Cluster C

Venous Flow Optimization Platform

Targets:

• Venous stasis
• Circulatory efficiency
• Valve preservation

⸻

SCF Target Cluster D

Embolism Prevention Platform

Targets:

• Thrombus stabilization
• Embolic prevention
• Pulmonary protection

⸻

15. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Coagulation

• D-dimer
• Fibrinogen
• Thrombin generation markers

Platelet Activity

• Soluble P-selectin
• Platelet activation markers

Endothelial Injury

• von Willebrand factor
• Angiopoietin-2
• Soluble thrombomodulin

Inflammation

• CRP
• IL-6
• TNF-α

⸻

Clinical Endpoints

Primary

• Complete thrombus stabilization and resolution

Secondary

• Prevention of pulmonary embolism
• Reduction in recurrent thrombosis
• Prevention of post-thrombotic syndrome
• Preservation of venous function

⸻

FDA TRANSLATIONAL PATHWAY

Preclinical

↓

IND

↓

Phase I Safety

↓

Phase II Venous Thromboembolism Studies

↓

Phase III Maternal Thromboembolism Prevention and Treatment Trials

↓

NDA/BLA Submission

⸻

16. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Platelets, leukocytes, and endothelial cells become excessively biased toward coagulation rather than circulatory homeostasis.

⸻

Tissue Layer

Venous structures lose the ability to maintain unobstructed blood flow due to progressive thrombus accumulation.

⸻

Organ Layer

The venous circulation system develops localized obstruction that threatens regional and systemic perfusion dynamics.

⸻

System Layer

Coagulation, inflammation, endothelial regulation, and circulatory control systems become synchronized into a prothrombotic state.

⸻

Whole-Organism Layer

The maternal organism amplifies protective postpartum hemostatic mechanisms beyond physiologic necessity, producing pathologic thrombosis that can threaten life through embolic dissemination.

⸻

17. SCF LAYMAN’S SUMMARY

Deep Vein Thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the leg or pelvis, after childbirth.

According to the SCF model, the postpartum body naturally becomes more prone to clotting in order to prevent excessive bleeding after delivery. In some women, this protective clotting response becomes excessive and combines with reduced movement, blood vessel injury, or inherited clotting tendencies to form dangerous blood clots.

Common symptoms include:

• Swelling of one leg
• Pain or tenderness in the calf or thigh
• Warmth of the affected limb
• Redness or discoloration
• Pelvic pain in some cases

The most serious complication occurs when part of the clot breaks loose and travels to the lungs, causing a pulmonary embolism, which is a life-threatening emergency.

Early diagnosis and treatment with anticoagulation therapy can greatly reduce the risk of complications.

⸻

SCF-RDOS INDICATION SUMMARY

⸻

INDEX

SCF Master Registry Classification

• SCF-RDOS-PPD-VASC-001 — Deep Vein Thrombosis (DVT)

Domain Pathway:

Postpartum Disorders → Vascular Disorders → Venous Thromboembolic Syndromes → Deep Venous Thrombosis

SCF Encyclopedia Series: Maternal Postpartum Disorders Encyclopedia (Vascular, Hematologic & Thromboembolic Volume) Version 1.0.0